Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
about
Resistant mechanisms to BRAF inhibitors in melanomaTumour progression and metastasisEpigenetic mechanisms involved in melanoma pathogenesis and chemoresistanceAdapt, Recycle, and Move on: Proteostasis and Trafficking Mechanisms in MelanomaEpigenetic determinants of metastasisComprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanomaEpigenetic inactivation of the p53-induced long noncoding RNA TP53 target 1 in human cancer.The epigenomic basis of common diseases.CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.Precision medicine based on epigenomics: the paradigm of carcinoma of unknown primary.Genome-wide methylation sequencing of paired primary and metastatic cell lines identifies common DNA methylation changes and a role for EBF3 as a candidate epigenetic driver of melanoma metastasis.Histone variants and melanoma: facts and hypotheses.DNA methylation plasticity contributes to the natural history of metastasis.Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.Consequences of Rab GTPase dysfunction in genetic or acquired human diseases.A non-coding function of TYRP1 mRNA promotes melanoma growth.Investigation of correlations between DNA methylation, suicidal behavior and aging.DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats.Targeting melanoma: unusual epigenetics reveals the dynamic rewiring of metastatic cells.
P2860
Q26739717-FF6164C6-64CE-4D14-BE70-F4F2B1BC9B96Q26766468-69EBDC2D-6A18-413D-A55C-BDD313FDABA1Q26778761-7316DB76-FE53-47D2-91FE-9ACB8E407F65Q28069018-4A3F48D0-26A7-4A9B-B82B-F193FBC1DCF5Q28079377-D428023E-C799-4B6A-B838-02D366F8C44AQ33762715-B975FCAF-12F5-4D1B-B174-8D393B709DE2Q37451300-9F882D19-4B9A-4786-BA0B-7E63394BC0CFQ37609851-CE2959EB-20E5-4424-8241-CA53987554EBQ37716619-FA2516DE-40B9-44AB-AAA0-C98304CFEB11Q38694763-20269362-D883-4EB1-B095-C10FF718F353Q38723959-A8730F77-247E-4B15-9FC4-AA1C902FDEA9Q38748010-1D3AF0ED-8133-491A-9F9F-60E6E0D12F60Q39983760-CE031F50-935E-437E-BC8A-08C71EBDD4B4Q42281992-98316495-F99F-4E48-AA68-8C447B0E6EFCQ47294747-DDD93398-0A01-460E-A62F-8EC55CDA718DQ47678258-EB072365-C548-4F25-970C-8EAF9EA582DFQ47780882-EED8C9F9-F442-49AB-BBAA-9DB578D66E44Q48293367-7AF719EB-B584-4D21-97CD-BA0E62CE5EF3Q55037254-21AA17B9-DEB1-470B-8774-F63661FF5F1C
P2860
Epigenetic activation of a cryptic TBC1D16 transcript enhances melanoma progression by targeting EGFR
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on June 2015
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Epigenetic activation of a cry ...... progression by targeting EGFR
@en
Epigenetic activation of a cry ...... progression by targeting EGFR.
@nl
type
label
Epigenetic activation of a cry ...... progression by targeting EGFR
@en
Epigenetic activation of a cry ...... progression by targeting EGFR.
@nl
prefLabel
Epigenetic activation of a cry ...... progression by targeting EGFR
@en
Epigenetic activation of a cry ...... progression by targeting EGFR.
@nl
P2093
P2860
P50
P356
P1433
P1476
Epigenetic activation of a cry ...... progression by targeting EGFR
@en
P2093
Alberto Villanueva
Alfonso Berrocal
Catia Moutinho
Dennie T Frederick
Elena Elez
Eva Muñoz-Couselo
F Javier Carmona
Joost van den Oord
Jose L Manzano
P2860
P2888
P304
P356
10.1038/NM.3863
P407
P50
P577
2015-06-01T00:00:00Z